The Companion Diagnostics Market Size, valued at USD 7.66 billion in 2023, is projected to grow at a robust CAGR of 11.9% to reach an estimated USD 21.15 billion by 2032, according to the latest market research. The substantial growth reflects the rising importance of personalized medicine, expanding oncology diagnostics, and ongoing advancements in biomarker-based testing platforms. Companion...